N-cyclopropyl-1-[2-(ethylcarbamoylamino)-7-pyridin-1-ium-1-yl-3H-benzimidazol-5-yl]imidazole-4-carboxamide;1-ethyl-3-[4-(4-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(6-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(4-methyl-2-pyridinyl)-6-[2-oxo-1-(2-oxobutyl)-4-pyridinyl]-1H-benzimidazol-2-yl]urea

C87H87N28O9+ — CID 157264075

IUPACN-cyclopropyl-1-[2-(ethylcarbamoylamino)-7-pyridin-1-ium-1-yl-3H-benzimidazol-5-yl]imidazole-4-carboxamide;1-ethyl-3-[4-(4-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(6-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(4-methyl-2-pyridinyl)-6-[2-oxo-1-(2-oxobutyl)-4-pyridinyl]-1H-benzimidazol-2-yl]urea
SMILESCCNC(=O)Nc1nc2c(-[n+]3ccccc3)cc(-n3cnc(C(=O)NC4CC4)c3)cc2[nH]1.CCNC(=O)Nc1nc2c(-c3cc(C)ccn3)cc(-c3ccn(CC(=O)CC)c(=O)c3)cc2[nH]1.CCNC(=O)Nc1nc2c(-c3cc(OC)ccn3)cc(-c3cncnc3)cc2[nH]1.CCNC(=O)Nc1nc2c(-c3cccc(OC)n3)cc(-c3cncnc3)cc2[nH]1
InChIInChI=1S/C25H26N6O3.C22H22N8O2.2C20H19N7O2/c1-4-18(32)14-31-9-7-16(13-22(31)33)17-11-19(20-10-15(3)6-8-27-20)23-21(12-17)28-24(29-23)30-25(34)26-5-2;1-2-23-22(32)28-21-26-16-10-15(11-18(19(16)27-21)29-8-4-3-5-9-29)30-12-17(24-13-30)20(31)25-14-6-7-14;1-3-23-20(28)27-19-25-17-7-12(13-9-21-11-22-10-13)6-15(18(17)26-19)16-8-14(29-2)4-5-24-16;1-3-23-20(28)27-19-25-16-8-12(13-9-21-11-22-10-13)7-14(18(16)26-19)15-5-4-6-17(24-15)29-2/h6-13H,4-5,14H2,1-3H3,(H3,26,28,29,30,34);3-5,8-14H,2,6-7H2,1H3,(H3-,23,25,26,27,28,31,32);2*4-11H,3H2,1-2H3,(H3,23,25,26,27,28)/p+1
InChIKeyCUIJRKOJYQBKSK-UHFFFAOYSA-O
MW1668.84 g/mol
LogP12.41
Rot. Bonds23

About N-cyclopropyl-1-[2-(ethylcarbamoylamino)-7-pyridin-1-ium-1-yl-3H-benzimidazol-5-yl]imidazole-4-carboxamide;1-ethyl-3-[4-(4-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(6-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(4-methyl-2-pyridinyl)-6-[2-oxo-1-(2-oxobutyl)-4-pyridinyl]-1H-benzimidazol-2-yl]urea

N-cyclopropyl-1-[2-(ethylcarbamoylamino)-7-pyridin-1-ium-1-yl-3H-benzimidazol-5-yl]imidazole-4-carboxamide;1-ethyl-3-[4-(4-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(6-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(4-methyl-2-pyridinyl)-6-[2-oxo-1-(2-oxobutyl)-4-pyridinyl]-1H-benzimidazol-2-yl]urea (PubChem CID 157264075) has the molecular formula C87H87N28O9+ and a molecular weight of 1668.84 g/mol. Its IUPAC name is N-cyclopropyl-1-[2-(ethylcarbamoylamino)-7-pyridin-1-ium-1-yl-3H-benzimidazol-5-yl]imidazole-4-carboxamide;1-ethyl-3-[4-(4-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(6-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(4-methyl-2-pyridinyl)-6-[2-oxo-1-(2-oxobutyl)-4-pyridinyl]-1H-benzimidazol-2-yl]urea.

Molecular Properties

Compound NameN-cyclopropyl-1-[2-(ethylcarbamoylamino)-7-pyridin-1-ium-1-yl-3H-benzimidazol-5-yl]imidazole-4-carboxamide;1-ethyl-3-[4-(4-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(6-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(4-methyl-2-pyridinyl)-6-[2-oxo-1-(2-oxobutyl)-4-pyridinyl]-1H-benzimidazol-2-yl]urea
PubChem CID157264075
Molecular FormulaC87H87N28O9+
Molecular Weight1668.84 g/mol
Exact Mass1667.72
IUPAC NameN-cyclopropyl-1-[2-(ethylcarbamoylamino)-7-pyridin-1-ium-1-yl-3H-benzimidazol-5-yl]imidazole-4-carboxamide;1-ethyl-3-[4-(4-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(6-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(4-methyl-2-pyridinyl)-6-[2-oxo-1-(2-oxobutyl)-4-pyridinyl]-1H-benzimidazol-2-yl]urea
SMILESCCNC(=O)Nc1nc2c(-[n+]3ccccc3)cc(-n3cnc(C(=O)NC4CC4)c3)cc2[nH]1.CCNC(=O)Nc1nc2c(-c3cc(C)ccn3)cc(-c3ccn(CC(=O)CC)c(=O)c3)cc2[nH]1.CCNC(=O)Nc1nc2c(-c3cc(OC)ccn3)cc(-c3cncnc3)cc2[nH]1.CCNC(=O)Nc1nc2c(-c3cccc(OC)n3)cc(-c3cncnc3)cc2[nH]1
InChIInChI=1S/C25H26N6O3.C22H22N8O2.2C20H19N7O2/c1-4-18(32)14-31-9-7-16(13-22(31)33)17-11-19(20-10-15(3)6-8-27-20)23-21(12-17)28-24(29-23)30-25(34)26-5-2;1-2-23-22(32)28-21-26-16-10-15(11-18(19(16)27-21)29-8-4-3-5-9-29)30-12-17(24-13-30)20(31)25-14-6-7-14;1-3-23-20(28)27-19-25-17-7-12(13-9-21-11-22-10-13)6-15(18(17)26-19)16-8-14(29-2)4-5-24-16;1-3-23-20(28)27-19-25-16-8-12(13-9-21-11-22-10-13)7-14(18(16)26-19)15-5-4-6-17(24-15)29-2/h6-13H,4-5,14H2,1-3H3,(H3,26,28,29,30,34);3-5,8-14H,2,6-7H2,1H3,(H3-,23,25,26,27,28,31,32);2*4-11H,3H2,1-2H3,(H3,23,25,26,27,28)/p+1
InChIKeyCUIJRKOJYQBKSK-UHFFFAOYSA-O
XLogP12.41
TPSA477.80 Ų
H-Bond Donors13
H-Bond Acceptors23
Rotatable Bonds23
Heavy Atoms124
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001668.84
LogP ≤ 512.41
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze N-cyclopropyl-1-[2-(ethylcarbamoylamino)-7-pyridin-1-ium-1-yl-3H-benzimidazol-5-yl]imidazole-4-carboxamide;1-ethyl-3-[4-(4-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(6-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(4-methyl-2-pyridinyl)-6-[2-oxo-1-(2-oxobutyl)-4-pyridinyl]-1H-benzimidazol-2-yl]urea with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-cyclopropyl-1-[2-(ethylcarbamoylamino)-7-pyridin-1-ium-1-yl-3H-benzimidazol-5-yl]imidazole-4-carboxamide;1-ethyl-3-[4-(4-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(6-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(4-methyl-2-pyridinyl)-6-[2-oxo-1-(2-oxobutyl)-4-pyridinyl]-1H-benzimidazol-2-yl]urea?
The IUPAC name of N-cyclopropyl-1-[2-(ethylcarbamoylamino)-7-pyridin-1-ium-1-yl-3H-benzimidazol-5-yl]imidazole-4-carboxamide;1-ethyl-3-[4-(4-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(6-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(4-methyl-2-pyridinyl)-6-[2-oxo-1-(2-oxobutyl)-4-pyridinyl]-1H-benzimidazol-2-yl]urea (CID 157264075) is N-cyclopropyl-1-[2-(ethylcarbamoylamino)-7-pyridin-1-ium-1-yl-3H-benzimidazol-5-yl]imidazole-4-carboxamide;1-ethyl-3-[4-(4-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(6-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(4-methyl-2-pyridinyl)-6-[2-oxo-1-(2-oxobutyl)-4-pyridinyl]-1H-benzimidazol-2-yl]urea.
What is the SMILES notation for N-cyclopropyl-1-[2-(ethylcarbamoylamino)-7-pyridin-1-ium-1-yl-3H-benzimidazol-5-yl]imidazole-4-carboxamide;1-ethyl-3-[4-(4-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(6-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(4-methyl-2-pyridinyl)-6-[2-oxo-1-(2-oxobutyl)-4-pyridinyl]-1H-benzimidazol-2-yl]urea?
The canonical SMILES for N-cyclopropyl-1-[2-(ethylcarbamoylamino)-7-pyridin-1-ium-1-yl-3H-benzimidazol-5-yl]imidazole-4-carboxamide;1-ethyl-3-[4-(4-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(6-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(4-methyl-2-pyridinyl)-6-[2-oxo-1-(2-oxobutyl)-4-pyridinyl]-1H-benzimidazol-2-yl]urea is CCNC(=O)Nc1nc2c(-[n+]3ccccc3)cc(-n3cnc(C(=O)NC4CC4)c3)cc2[nH]1.CCNC(=O)Nc1nc2c(-c3cc(C)ccn3)cc(-c3ccn(CC(=O)CC)c(=O)c3)cc2[nH]1.CCNC(=O)Nc1nc2c(-c3cc(OC)ccn3)cc(-c3cncnc3)cc2[nH]1.CCNC(=O)Nc1nc2c(-c3cccc(OC)n3)cc(-c3cncnc3)cc2[nH]1.
What is the InChIKey of N-cyclopropyl-1-[2-(ethylcarbamoylamino)-7-pyridin-1-ium-1-yl-3H-benzimidazol-5-yl]imidazole-4-carboxamide;1-ethyl-3-[4-(4-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(6-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(4-methyl-2-pyridinyl)-6-[2-oxo-1-(2-oxobutyl)-4-pyridinyl]-1H-benzimidazol-2-yl]urea?
The InChIKey is CUIJRKOJYQBKSK-UHFFFAOYSA-O. The full InChI is InChI=1S/C25H26N6O3.C22H22N8O2.2C20H19N7O2/c1-4-18(32)14-31-9-7-16(13-22(31)33)17-11-19(20-10-15(3)6-8-27-20)23-21(12-17)28-24(29-23)30-25(34)26-5-2;1-2-23-22(32)28-21-26-16-10-15(11-18(19(16)27-21)29-8-4-3-5-9-29)30-12-17(24-13-30)20(31)25-14-6-7-14;1-3-23-20(28)27-19-25-17-7-12(13-9-21-11-22-10-13)6-15(18(17)26-19)16-8-14(29-2)4-5-24-16;1-3-23-20(28)27-19-25-16-8-12(13-9-21-11-22-10-13)7-14(18(16)26-19)15-5-4-6-17(24-15)29-2/h6-13H,4-5,14H2,1-3H3,(H3,26,28,29,30,34);3-5,8-14H,2,6-7H2,1H3,(H3-,23,25,26,27,28,31,32);2*4-11H,3H2,1-2H3,(H3,23,25,26,27,28)/p+1.
What are the key properties of N-cyclopropyl-1-[2-(ethylcarbamoylamino)-7-pyridin-1-ium-1-yl-3H-benzimidazol-5-yl]imidazole-4-carboxamide;1-ethyl-3-[4-(4-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(6-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(4-methyl-2-pyridinyl)-6-[2-oxo-1-(2-oxobutyl)-4-pyridinyl]-1H-benzimidazol-2-yl]urea?
N-cyclopropyl-1-[2-(ethylcarbamoylamino)-7-pyridin-1-ium-1-yl-3H-benzimidazol-5-yl]imidazole-4-carboxamide;1-ethyl-3-[4-(4-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(6-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(4-methyl-2-pyridinyl)-6-[2-oxo-1-(2-oxobutyl)-4-pyridinyl]-1H-benzimidazol-2-yl]urea has a molecular weight of 1668.84 g/mol, XLogP of 12.41, 23 rotatable bonds, 13 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for N-cyclopropyl-1-[2-(ethylcarbamoylamino)-7-pyridin-1-ium-1-yl-3H-benzimidazol-5-yl]imidazole-4-carboxamide;1-ethyl-3-[4-(4-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(6-methoxy-2-pyridinyl)-6-pyrimidin-5-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(4-methyl-2-pyridinyl)-6-[2-oxo-1-(2-oxobutyl)-4-pyridinyl]-1H-benzimidazol-2-yl]urea is sourced from PubChem (CID 157264075), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).